News

Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes ...
Vivani Medical, Inc.: Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature ...
Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs
Vivani Medical (VANI) and Okava Pharmaceuticals announced an expansion of their collaboration to include dogs in the development of OKV-119, a ...
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases ...
Times Union16d
Vivani Medical: Q4 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Monday reported a loss of $6.1 million in its fourth quarter. On a per-share basis, the Alameda, California-based ...
TMCnet16d
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
ALAMEDA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, ultra long-acting drug ...
Vivani Medical: Q4 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Monday reported a loss of $6.1 million in its fourth quarter. On a per-share basis, the Alameda, California-based company ...